Demonstration program of population-based lung cancer screening in China: Rationale and study design
- PMID: 26767001
- PMCID: PMC4704303
- DOI: 10.1111/1759-7714.12078
Demonstration program of population-based lung cancer screening in China: Rationale and study design
Abstract
Background: Lung cancer is the leading cause of cancer-related death and has become an enormous economic burden in China. Low-dose spiral computed tomography (LDCT) screening could reduce lung cancer mortality. The feasibility of conducting a population-based lung cancer screening with LDCT in China is uncertain.
Methods: In 2010, a demonstration program of lung cancer screening was initiated in China. High-risk individuals were enrolled in a cluster sampling design in different centers. Participants received baseline and annual screening with spiral CT and follow-up information was collected. The objective of this program is to evaluate the feasibility of conducting population-based LDCT lung cancer screening in the Chinese context. The rates of detection, early diagnosis and treatment are defined as indicators of program performance. The optimal management strategies for nodules are explored in the Chinese context based on experiences in other studies overseas.
Results: A demonstration program of ongoing prospective, multi-center, population-based lung cancer screening is being performed in China.
Conclusions: This demonstration program will provide opportunities to explore the feasibility of LDCT lung cancer screening in the Chinese setting.
Keywords: Feasibility study; lung cancer; mass screening; spiral computed tomography.
Figures
Similar articles
-
Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.Thorac Cancer. 2020 May;11(5):1224-1232. doi: 10.1111/1759-7714.13379. Epub 2020 Mar 20. Thorac Cancer. 2020. PMID: 32196998 Free PMC article.
-
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.Lancet Respir Med. 2022 Apr;10(4):378-391. doi: 10.1016/S2213-2600(21)00560-9. Epub 2022 Mar 8. Lancet Respir Med. 2022. PMID: 35276087
-
[China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version)].Zhongguo Fei Ai Za Zhi. 2018 Feb 20;21(2):67-75. doi: 10.3779/j.issn.1009-3419.2018.02.01. Zhongguo Fei Ai Za Zhi. 2018. PMID: 29526173 Free PMC article. Chinese.
-
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2. Cochrane Database Syst Rev. 2022. PMID: 35921047 Free PMC article. Review.
-
Screening for Lung Cancer With Low-Dose Computed Tomography: An Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-1. PMID: 33750087 Free Books & Documents. Review.
Cited by
-
Poor sleep quality association with higher lung cancer risk: a nested case-control study.PeerJ. 2023 Dec 15;11:e16540. doi: 10.7717/peerj.16540. eCollection 2023. PeerJ. 2023. PMID: 38111660 Free PMC article.
-
Meta analysis of the diagnostic value of circulating miRNA in benign and malignant pulmonary nodules.World J Surg Oncol. 2023 Sep 9;21(1):284. doi: 10.1186/s12957-023-03133-3. World J Surg Oncol. 2023. PMID: 37689670 Free PMC article.
-
The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer.Front Oncol. 2022 Sep 27;12:902955. doi: 10.3389/fonc.2022.902955. eCollection 2022. Front Oncol. 2022. PMID: 36237340 Free PMC article.
-
Epidemiological trends and incidence prediction of lung cancer in China based on the Global Burden of Disease study 2019.Front Med (Lausanne). 2022 Sep 20;9:969487. doi: 10.3389/fmed.2022.969487. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36203776 Free PMC article.
-
The impact of low-dose CT on smoking behavior among non-smokers, former-smokers, and smokers: A population-based screening cohort in rural China.Cancer Med. 2023 Feb;12(4):4667-4678. doi: 10.1002/cam4.5073. Epub 2022 Jul 27. Cancer Med. 2023. PMID: 35894767 Free PMC article.
References
-
- Ferlay J. Shin HR. Bray F. Forman D. Mathers C. Parkin DM. Estimates of worldwide burden of cancer in GLOBOCAN. Int J Cancer. 2008;127:2893–2917. - PubMed
-
- MoHotpsro C. Report of the Third National Retrospective Survey of Death Causes in China. Beijing: Chinese Academy of Medical Sciences & Peking Union Medical College Press; 2010.
-
- Wang MWY, Guo B, et al. Status quo and issues of direct impatient cost of lung carcinoma in China. Chin Health Econ. 2007;26:59–62. . (In Chinese.)
-
- Boffetta P, Agudo A, Ahrens W, et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst. 1998;90:1440–1450. - PubMed
-
- Krewski D, Lubin JH, Zielinski JM, et al. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology. 2005;16:137–145. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
